Cellink
Pre-clinicalCELLINK leads the way in 3D bioprinting innovation, developing bioprinters and bioinks for pharma, academic and industry researchers.
Founded
2016
Focus
Regenerative MedicineMedical Devices
About
CELLINK leads the way in 3D bioprinting innovation, developing bioprinters and bioinks for pharma, academic and industry researchers.
Funding History
3Total raised: $20.5M
Series B$15MUndisclosedJun 15, 2019
Series A$5MUndisclosedJun 15, 2017
Seed$500KUndisclosedJun 15, 2016
Company Info
TypePrivate
Founded2016
LocationGothenburg, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile